Some analysts have predicted the market for weight-loss drugs could reach $100 billion a year by the end of the decade, with Ozempic maker Novo Nordisk and Mounjaro producer Eli Lilly leading the race. The use of GLP-1s could increase by anywhere between 10 to 70 million consumers by 2028, Goldman Sachs said on Thursday. “If GLP-1 usage ultimately increases by this amount and results in lower obesity rates, we see scope for significant spillovers to the broader economy,” Goldman economists said in a note.
Related Posts
Trevor Lawrence, Lamar Jackson and Nick Sirianni are Under Duress in Week 3 | First Things First
Chris Broussard unveils his Week 3 BUD list, featuring Nick Sirianni and Lamar Jackson’s returns and the Prince. Nick Wright, Kevin Wildes and Coach Eric Mangini chime in and share their nominees, featuring Brandon Aiyuk, rookie QBs and player podcasts (sorry, Micah Parsons).
Eagles (+2.5) cover vs Saints, Cowboys (+1) bounce back, Bears (+1.5) win in Week 3 | What’s Wright?
Nick Wright unveils his Week 3 picks, including the Philadelphia Eagles covering against the New Orleans Saints, Dallas Cowboys (+1) bouncing back at home and the Chicago Bears (+1.5) defeating the Indianapolis Colts.
Dodgers’ Shohei Ohtani becomes first MLB player to post 50/50 season
Dodgers superstar Shohei Ohtani hit three home runs and stole two bases Thursday to became the first player in MLB history to post a 50/50 season.